Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Our program is designed to be a comprehensive partner in your health journey
Semaglutide and tirzepatide are effective treatments for managing obesity
Your provider will determine: your starting dose when to increase your dose whether your body is tolerating treatment well when to hold, continue, or adjust your program Dose changes should always be guided by a licensed medical provider
Regarding pediatric use, Wegovy is approved for chronic weight management in patients aged 12 years and older with obesity, while Zepbound is approved only for adults 18 years and older
US$ 25.43
US$ 21.91
US$ 27.37
US$ 26.96
US$ 24.21
